The possibility that childhood cancer is increased in the vicinity of nuclear installations4 was first suggested by the observation of an increased incidence of childhood acute lymphoblastic leukaemia (ALL) in the village of Seascale, close to the Sellafield nuclear plant.3 At first it seemed likely that the cause of the observed excess of ALL was environmental radionuclide contamination from Sellafield nuclear plant, but detailed physiological and mathematical models indicated that exposure experienced by Seascale residents from Sellafield discharges was less than natural background radiation.5 The population of Seascale is unusual in that it consists predominantly of higher socioeconomic groups, mobility is high, and the area is relatively isolated, all factors which have been associated with a higher incidence of childhood leukaemia."8 Initially these associations were suggested to be related to an altered response to infection9 but recently it has been shown that men who worked in the Sellafield plant were at increased risk of fathering a child with leukaemia and the risk was related to the degree of preconceptional radiation exposure.'0 This observation has led to speculation that the increased incidence of leukaemia is the result of radiation damage to spermatozoa." 12 This would imply a fifty-fold increase in the oocyte mutation rate and is not consistent with the apparent radiation exposure of Seascale children.5 An alternate and more plausible hypothesis involves radiation induced somatic mutation in utero. All cell generations would be exposed throughout intrauterine development and the expectation of childhood cancer would be proportional to the mutation rate raised to the power n, where n is the number of mutations for cancer.'415 This would only require a four-fold increase in the mutation rate to get a sixteen-fold increase in the expectation of retinoblastoma, and although much higher than the known exposure levels in the mother, there might be some mechanism by which radionuclides are transferred across the placenta and concentrated in the developing fetus.
Molecular genetic studies Dr Cowell indicated that participants at the meeting agreed that study of the DNA from the subjects with retinoblastoma offered the best available method for solving the puzzle and molecular genetics might distinguish somatic mutations in utero from germline mutations. The DNA sequence of the retinoblastoma gene (RB1) is known and oligonucleotide primers are available to amplify by PCR each of the 27 exons of RB1, including the coding regions and the splice junction regions, although mutations of the promoter/enhancer regions upstream of the initiation codon might be missed by this procedure. Once each exon of the gene has been amplified using PCR it can be analysed by single strand conformation polymorphism (SSCP), '6 
